Security Reports > Amgen
Amgen
Data Breaches, Cyber Attacks and Security Report
https://amgen.com ᛫ Biotech & Pharmaceuticals
Last updated August 4, 2020
https://amgen.com ᛫ Biotech & Pharmaceuticals
Last updated August 4, 2020
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Amgen is implementing good security practices.
Amgen Inc. (formerly Applied Molecular Genetics Inc.) is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. In 2013, the company's largest selling product lines were Neulasta/Neupogen, two closely related drugs used to prevent infections in patients undergoing cancer chemotherapy; and Enbrel, a tumor necrosis factor blocker used in the treatment of rheumatoid arthritis and other autoimmune diseases.
This report shows a preliminary security rating for Amgen. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.
Get a deeper scan →Read more about the latest issues in cybersecurity
Compare Amgen's security performance with other companies